Ariel Lopez-Chavez, M.D., M.S.

Specialty:: Cancer and Blood Disorders
Special Interests:: Lung Cancer, Mesothelioma, Thymoma and Thymic Malignancies
Accepting Patients:: Yes
Languages:: English, Spanish

Academic and Clinical Position

Assistant Professor

Biography

Dr. Lopez-Chavez specializes in the use of novel molecular tools and targeted therapies for the care of patients with lung cancer and other thoracic malignancies. By personalizing treatments based on the unique patient characteristics and the molecular and cellular changes that are specific to the cancer, Dr. Lopez-Chavez aims to find cancer therapies that may be more effective than other types of treatment, such as chemotherapy and radiotherapy, and less harmful to the patients.

In collaboration with the National Cancer Institute, Dr. Lopez-Chavez is leading a cutting edge clinical trial that allows patients with all types of lung cancer and thymic malignancies, to have their cancer undergo an extensive panel of molecular tests and then receive treatment with targeted therapies based on the results of such analysis. This is a very unique clinical trial that offers patients the opportunity to receive truly personalized cancer care and is only available at OHSU Knight Cancer Institute and the National Cancer Institute in Bethesda, Maryland. In addition to this trial, Dr. Lopez-Chavez is involved in numerous clinical trials that focus on the use of novel targeted therapies for the treatment of lung cancer and other thoracic malignancies.

Professional Education

Degrees:
M.D., Autonomous University of Queretaro, Querétaro, Mexico
MSc, National Autonomous University of Mexico, Mexico City, Mexico
Residency:
Internal Medicine, University of Pittsburgh Medical Center (Pittsburgh, PA)
Fellowships:
Medical Oncology, National Cancer Institute (Bethesda, MD)
Thoracic Oncology, National Cancer Institute (Bethesda, MD)